Loading...
In the PROMISE trial, researchers randomized 10,000 symptomatic outpatients without known coronary artery disease (CAD) to anatomic testing (computed tomography angiography [CTA]) or functional testing (exercise treadmill testing, stress echocardiography, or nuclear stress testing) to evaluate for obstructive CAD. At a median follow-up of 25 months, the primary and secondary outcomes, which included all-cause mortality and myocardial infarction, were not significantly different among the testing groups (NEJM JW Gen Med Apr 15 2015 and N Engl J Med 2015; 372:1291). In this new analysis, researchers evaluated costs for the anatomic and functional strategies.
At 90 days, mean costs for the CTA group versus the functional group were not signific…